Dr. Te Wu, PfMP, PgMP, PMP, PMI-RMP by CMK SELECT CMK SELECT CMK SELECT
CMK SELECT CMK SELECT CMK SELECT
Prof. Dr. Te Wu is the CPO and Executive Advisor with CMK Select, a leading management consulting firm focusing on the life science sector. In addition, he is the founder and CEO of PMO Advisory, a highly specialized project management training and advisory firm. He is also a professor at Montclair State University and China
CMK SELECT
43 Route 46 East, Suite 705 Pine Brook, NJ 07058 USA
Rachel Phone: (973) 244-6060

FORGOT YOUR DETAILS?

Dr. Te Wu, PfMP, PgMP, PMP, PMI-RMP

CPO and Executive Advisor

Prof. Dr. Te Wu is the CPO and Executive Advisor with CMK Select, a leading management consulting firm focusing on the life science sector. In addition, he is the founder and CEO of PMO Advisory, a highly specialized project management training and advisory firm. He is also a professor at Montclair State University and China Europe International Business School (CEIBS), which is currently ranked as the #5 MBA program in the world by Financial Times.

Dr. Wu has 25 years+ of experience specializing in strategy execution. Te is certified in Portfolio (PfMP), Program (PgMP), Project (PMP), and Risk Management (PMI-RMP). He is also an award-winning PM, earning Honorable Mention in PMI’s 2015 Project of the Year. He is an active volunteer with PMI including serving on the Portfolio Management and Risk Management Standard Core Teams. He is also a United States delegate on the International Standard Organization Technical Committee 258 for Project, Program and Portfolio Management. As a practitioner, executive, teacher, researcher, and speaker, Dr. Wu enjoys sharing and networking with project professionals of all levels.

EDUCATION:

BE, BA, Chemical Engineering, Philosophy from Stevens Institute of Technology
MBA from University of Phoenix
MA, Industrial Engineering from Columbia University
Doctoral of Professional Studies, International Business and Management from Pace University

PERSONAL FACT:

... KNOWLEDGE & INSIGHTS

CMK SELECT

DRUG SAFETY-RELATED LABELING CHANGES (SrLC) – PART II

AUTHOR: CMK SELECT

BENEFITS OF CENTRALIZING THE LABEL UPDATE PROCESS ACROSS AN ORGANIZATION Pharmaceutical marketing departments that centralize and standardize their approach to required label/Important Safety Information (ISI) updates, including the advance planning of upcoming labeling changes and continued optimization of their internal…
CONTINUE READING
CMK SELECT

DRUG SAFETY-RELATED LABELING CHANGES (SrLC) – PART I

AUTHOR: CMK SELECT

EFFICENTLY MANAGING REVISIONS TO MARKETING MATERIALS At any time during the active marketing of a pharmaceutical product, there is a high probability of having to implement a safety label update, impacting the Important Safety Information (ISI) that is highlighted in…
CONTINUE READING

LIKE OUR PAGE

FOLLOW US

GET LINKED IN

TOP